Discovering Integration Ownership Before a Healthcare Demonstration
Frame integration questions around workflow, governance, and the specialists who need to review details.
Healthcare buyers often ask whether a product integrates before they have identified the workflow it must support. An account executive can turn that broad question into a useful evaluation by asking which system, team, data boundary, and approval path are involved. Technical and privacy specialists should validate detailed claims after discovery.
Avoid saying an integration is simple or guaranteed. Ask where staff begin work today, what information they need to see, and who owns architecture review. Then agree on a scoped demonstration that shows the relevant workflow and includes the appropriate customer reviewers.
In a fictional discovery call, Mia says, “Does it connect to our scheduling platform?” Colin replies, “We should map what your schedulers need to do and who reviews integrations on your side. Which step creates the most manual work today?” Mia says, “They copy appointment data into another queue.” Colin says, “That gives us a useful demonstration focus. I will bring our technical specialist to the next session and ask your integration and privacy owners what documentation they need.”
Before the next discovery call, write five workflow questions that cannot be answered with a product slogan. A manager can review whether each question reveals a decision owner or a requirement for the evaluation.
Practice these next
Help an internal advocate prepare a useful stakeholder conversation without asking them to sell unsupported claims.
Surface data retention owners and review needs without answering beyond approved materials.
Turn broad buyer interest into shared operational, technical, and commercial criteria for a fair evaluation.
Test whether an executive priority creates a useful evaluation question instead of an assumed solution.
Build a realistic stakeholder map by asking who reviews privacy, technology, operations, and commercial fit.
Healthcare account executives can ask about commercial process early without reducing discovery to price.